Bath & Body Works (NYSE:BBWI) Price Target Cut to $33.00 by Analysts at Wells Fargo & Company

Bath & Body Works (NYSE:BBWI) had its price objective cut by Wells Fargo & Company from $44.00 to $33.00 in a research note released on Monday, Marketbeat.com reports. They currently have an overweight rating on the stock.

Several other equities research analysts have also recently issued reports on BBWI. Barclays cut their price target on Bath & Body Works from $32.00 to $28.00 and set an “equal weight” rating for the company in a research note on Monday, October 20th. JPMorgan Chase & Co. restated a “neutral” rating and set a $26.00 target price on shares of Bath & Body Works in a research note on Monday, October 6th. Morgan Stanley cut their target price on Bath & Body Works from $19.00 to $18.00 and set an “overweight” rating for the company in a research note on Friday, September 12th. Wall Street Zen cut Bath & Body Works from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Finally, Telsey Advisory Group restated an “outperform” rating and set a $38.00 target price on shares of Bath & Body Works in a research note on Thursday, August 28th. Eleven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, Bath & Body Works presently has an average rating of “Moderate Buy” and an average target price of $36.39.

Bath & Body Works Trading Down 3.5%

Shares of BBWI stock opened at $26.05 on Monday. The stock has a market cap of $5.37 billion, a P/E ratio of 7.73, a price-to-earnings-growth ratio of 0.93 and a beta of 1.52. The stock has a 50 day simple moving average of $27.43 and a 200 day simple moving average of $29.06. Bath & Body Works has a 1 year low of $24.85 and a 1 year high of $41.87.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.37. The business had revenue of $1.55 billion during the quarter, compared to analysts’ expectations of $1.55 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The firm’s revenue for the quarter was down .8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Analysts forecast that Bath & Body Works will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.1%. The ex-dividend date was Friday, August 22nd. Bath & Body Works’s dividend payout ratio is presently 23.74%.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. First Horizon Corp bought a new position in shares of Bath & Body Works in the 3rd quarter valued at $29,000. Stonehage Fleming Financial Services Holdings Ltd bought a new position in shares of Bath & Body Works in the 2nd quarter valued at $33,000. SVB Wealth LLC bought a new position in shares of Bath & Body Works in the 1st quarter valued at $35,000. Geneos Wealth Management Inc. lifted its stake in shares of Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after acquiring an additional 801 shares during the last quarter. Finally, Parallel Advisors LLC lifted its stake in shares of Bath & Body Works by 63.3% in the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock valued at $37,000 after acquiring an additional 481 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.